This fall, researchers in South Africa began the largest clinical trial of a potential HIV/AIDS vaccine ever.
South Africa is home to almost a fifth of the world’s HIV-positive population.
“That vicious cycle of the older men who’d infect the young girls, and the young girls would infect their peers, that perpetuates the infection,” Helen Joseph Hospital Dr Sello Mashamaite told VICE News in Johannesburg, South Africa.
Continue Reading
The vaccine trial, known as HVTN 702, could lead to a breakthrough in preventing new cases. Researchers expect that the vaccine will be 50% effective, a significant improvement from a 2009 version that was 31% effective.
Results from the first 5400 recipients of the vaccine are expected in late 2020.
Reference
http://vicenews.com
Loading...
Loading...
Continuing Medical Education (CME/CE) Courses
Want to read more?
Please login or register first to view this content.
Enjoying our content?
Thanks for visiting The Medical Bag. We hope you’re enjoying the latest health care news coverage, and lifestyle and business advice.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on The Medical Bag. Register for free and gain unlimited access to the latest in medical news, and lifestyle and business advice, with personalized daily picks for you. There's something for every health care professional on The Medical Bag.
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.